Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07195708). This is a study registration, not published results. Lead sponsor: Boston Scientific Corporation. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 144 participants (ESTIMATED). Conditions: Weight Loss. Interventions: DEVICE: Treatment group. Primary outcome measures: %TBWL (Defined as the percentage of total body weight loss) , At 12 months after the intervention; The response rate at the 12th month after the intervention , At 12 months after the intervention. Brief summary: To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.